Factors Associated with Exercise-Induced Desaturation in Patients with Chronic Obstructive Pulmonary Disease

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2020 Oct 30

PMID 33122902

Citations 10

Authors

Chiung-Hsin Chang

Horng-Chyuan Lin

Chia-Hung Yang

Shu-Ting Gan

Chi-Hsien Huang

Fu-Tsai Chung

Han-Chung Hu

Shu-Min Lin

Chih-Hao Chang

Affiliations

Soon will be listed here.

Abstract

Purpose: The 6-min walk test (6MWT) is a useful tool to assess the physiologic function in patients with chronic obstructive pulmonary disease (COPD). The recent study showed that patients with COPD with oxygen desaturation during the 6MWT had an increased risk of exacerbation and death compared with those without oxygen desaturation. This study aimed to explore the potential risk factors for exercise-induced desaturation (EID) in patients with COPD.

Patients And Methods: Adult patients with COPD were enrolled from the Chang Gung Research Database between January 2013 and January 2017. Age, sex, body mass index, underlying diseases, medications, and results of the pulmonary function tests and 6MWT were retrospectively collected and analyzed.

Results: Among 1768 patients with COPD, 932 (52.7%) had oxygen desaturation, and the other 836 (47.3%) had no desaturation during the 6MWT. The patients with EID had a shorter 6-min walk distance than those without desaturation (352.08±120.29 vs 426.56±112.56, p<0.0001). In the multivariate logistic regression analysis, older age, female sex, lower forced expiratory volume in 1 s, and comorbidity with atrial fibrillation (AF) were associated with oxygen desaturation during the 6MWT. Patients with EID had higher exacerbation frequency than those without desaturation in the 1-year follow-up period (0.59±1.50 vs 0.34±1.26, p<0.0001). Patients with COPD with AF also had a higher rate of exacerbation requiring emergency department visit or hospitalization in the 1-year follow-up.

Conclusion: This study demonstrates that older age, low FEV1, and female sex are risk factors for EID. Desaturation during 6MWT is related to frequent acute exacerbation of COPD in the 1-year follow-up.

Citing Articles

Therapeutic efficacy and pharmacological mechanism of Bailing capsule on chronic obstructive pulmonary disease: a meta-analysis and network pharmacology.

Ma G, Jin Y Pharm Biol. 2024; 62(1):803-817.

PMID: 39460586 PMC: 11514402. DOI: 10.1080/13880209.2024.2415643.

Evaluation of novel indices of walking performance taking oxygen desaturation into account during six-minute walk test in cardiovascular disease patients.

Matsuoka Y, Horio T, Ono M, Yoshimura R, Fukuda K, Shimizu M Heart Vessels. 2024; 39(10):877-883.

PMID: 38734834 DOI: 10.1007/s00380-024-02411-8.

High-flow nasal oxygenation versus face mask oxygenation for preoxygenation in patients undergoing double-lumen endobronchial intubation: protocol of a randomised controlled trial.

He R, Fang Y, Jiang Y, Yao D, Li Z, Zheng W BMJ Open. 2024; 14(3):e080422.

PMID: 38485472 PMC: 10941151. DOI: 10.1136/bmjopen-2023-080422.

Early versus non-early desaturation during 6MWT in COPD patients: A follow-up study.

Agarwal M, Anand S, Patro M, Gothi D Lung India. 2023; 40(3):235-241.

PMID: 37148021 PMC: 10298809. DOI: 10.4103/lungindia.lungindia_404_22.

Prediction of exercise-induced desaturation in COPD patients without resting hypoxemia: a retrospective study.

Yang L, Shi M, Situ X, He J, Qumu S, Yang T BMC Pulm Med. 2022; 22(1):405.

PMID: 36348483 PMC: 9641883. DOI: 10.1186/s12890-022-02174-w.

References

Guazzi M, Dickstein K, Vicenzi M, Arena R . Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail. 2009; 2(6):549-55. DOI: 10.1161/CIRCHEARTFAILURE.109.881326. View

Decramer M, Janssens W . Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013; 1(1):73-83. DOI: 10.1016/S2213-2600(12)70060-7. View

Feary J, Rodrigues L, Smith C, Hubbard R, Gibson J . Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010; 65(11):956-62. DOI: 10.1136/thx.2009.128082. View

Hsieh M, Fang Y, Chung F, Lee C, Chang Y, Liu Y . Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis. J Thorac Dis. 2017; 9(9):3168-3176. PMC: 5708370. DOI: 10.21037/jtd.2017.08.53. View

Gupta R, Ruppel G, Espiritu J . Exercise-Induced Oxygen Desaturation during the 6-Minute Walk Test. Med Sci (Basel). 2020; 8(1). PMC: 7151576. DOI: 10.3390/medsci8010008. View

Perez T, Deslee G, Burgel P, Caillaud D, Le Rouzic O, Zysman M . Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities. Int J Chron Obstruct Pulmon Dis. 2019; 14:1399-1410. PMC: 6614586. DOI: 10.2147/COPD.S188412. View

Durheim M, Cyr D, Lopes R, Thomas L, Tsuang W, Gersh B . Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial. Int J Cardiol. 2015; 202:589-94. DOI: 10.1016/j.ijcard.2015.09.062. View

Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M . Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000; 161(2 Pt 1):487-92. DOI: 10.1164/ajrccm.161.2.9906015. View

Andrianopoulos V, Franssen F, Peeters J, Ubachs T, Bukari H, Groenen M . Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol. 2013; 190:40-6. DOI: 10.1016/j.resp.2013.10.002. View

10.

Liao K, Chen C . Incidence and risk factors of atrial fibrillation in Asian COPD patients. Int J Chron Obstruct Pulmon Dis. 2017; 12:2523-2530. PMC: 5574688. DOI: 10.2147/COPD.S143691. View

11.

Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. DOI: 10.1056/NEJMoa0909883. View

12.

Shao S, Chan Y, Kao Yang Y, Lin S, Hung M, Chien R . The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019; 28(5):593-600. DOI: 10.1002/pds.4713. View

13.

Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S . A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(15):1543-54. DOI: 10.1056/NEJMoa0805800. View

14.

Du H, Wonggom P, Tongpeth J, Clark R . Six-Minute Walk Test for Assessing Physical Functional Capacity in Chronic Heart Failure. Curr Heart Fail Rep. 2017; 14(3):158-166. DOI: 10.1007/s11897-017-0330-3. View

15.

Halpin D, Decramer M, Celli B, Kesten S, Leimer I, Tashkin D . Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial. Lung. 2011; 189(4):261-8. PMC: 3140935. DOI: 10.1007/s00408-011-9301-8. View

16.

Sidney S, Sorel M, Quesenberry Jr C, DeLuise C, Lanes S, Eisner M . COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128(4):2068-75. DOI: 10.1378/chest.128.4.2068. View

17.

Buch P, Friberg J, Scharling H, Lange P, Prescott E . Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003; 21(6):1012-6. DOI: 10.1183/09031936.03.00051502. View

18.

Mannino D, Doherty D, Buist A . Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2005; 100(1):115-22. DOI: 10.1016/j.rmed.2005.03.035. View

19.

Waatevik M, Johannessen A, Real F, Aanerud M, Hardie J, Bakke P . Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. Eur Respir J. 2016; 48(1):82-91. DOI: 10.1183/13993003.00975-2015. View

20.

Lettieri C, Nathan S, Browning R, Barnett S, Ahmad S, Shorr A . The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med. 2006; 100(10):1734-41. DOI: 10.1016/j.rmed.2006.02.004. View